Neurology · Toms River, NJ
NPI
1285692053
Since 2006
Specialty
Neurology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
633 Rte 37 W
Toms River, NJ, 08755
Phone (732) 240-4787
Groups this clinician bills Medicare through
Medicare paid, 2024
$253K
22,119 services
Medicare patients, 2024
788
Average age 76
Drug cost, 2024
$2.4M
4,274 prescriptions
Company payments, 2025
$1,842
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rocco Dipaola was code J0585 (injection, onabotulinumtoxina, 1 unit), 11,760 times for 19 patients. In total Rocco Dipaola billed 22,119 services in 27 codes, and Medicare paid $253K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 11,760 | 19 | $4.32 | $51K |
| J0588 Injection, incobotulinumtoxin a, 1 unit | Office | 8,285 | 12 | $2.46 | $20K |
| 99214 Office E&M - Established | Office | 829 | 577 | $99.93 | $83K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 331 | 295 | $13.70 | $4,536 |
| 99215 Office E&M - Established | Office | 145 | 130 | $148.27 | $21K |
| 99204 Office E&M - New | Office | 114 | 114 | $130.25 | $15K |
| 99213 Office E&M - Established | Office | 110 | 59 | $76.20 | $8,382 |
| 99205 Office E&M - New | Office | 82 | 82 | $179.34 | $15K |
| 64616 Musculoskeletal | Office | 82 | 31 | $155.13 | $13K |
| 95983 Electrical Nerve Conductivity | Office | 62 | 38 | $41.02 | $2,543 |
| 64612 Musculoskeletal | Office | 58 | 23 | $137.68 | $7,985 |
| 95984 Electrical Nerve Conductivity | Office | 45 | 29 | $36.12 | $1,625 |
| 95970 Electrical Nerve Conductivity | Office | 32 | 21 | $15.44 | $494 |
| 64642 Musculoskeletal | Office | 29 | 14 | $108.61 | $3,150 |
By year: 2022 $311K for 35,766 services; 2023 $255K for 25,399 services; 2024 $253K for 22,119 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rocco Dipaola prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 1,186 prescriptions and refills. In total Rocco Dipaola wrote 4,274 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 1,186 | 2,872 | 413 | $62K |
| Rytary Carbidopa/Levodopa | 185 | 355 | 42 | $342K |
| Donepezil Hcl Generic | 174 | 457 | 68 | $2,824 |
| Amantadine Amantadine Hcl | 158 | 322 | 59 | $8,346 |
| Primidone Generic | 155 | 305 | 54 | $6,303 |
| Gabapentin Generic | 150 | 322 | 60 | $4,763 |
| Botox Onabotulinumtoxina | 142 | 402 | 56 | $253K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 130 | 324 | 53 | $10K |
| Escitalopram Oxalate Generic | 115 | 265 | 45 | $1,618 |
| Propranolol Hcl Generic | 109 | 200 | 31 | $3,168 |
| Alprazolam Generic | 107 | 130 | 45 | $691 |
| Quetiapine Fumarate Generic | 100 | 189 | 27 | $4,362 |
| Mirtazapine Generic | 87 | 195 | 37 | $2,571 |
| Clonazepam Generic | 67 | 103 | 28 | $803 |
| Nuplazid Pimavanserin Tartrate | 64 | 68 | Under 11 | $342K |
Brand drugs: 705 claims; generic drugs: 3,569 claims; opioid claims: 43.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rocco Dipaola $1,842 ($1,842 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $533.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 20 | $533 |
| Amneal Pharmaceuticals LLC AMRX | 29 | $261 |
| Boston Scientific Corporation BSX | 2 | $185 |
| UCB, Inc. UCB.BR | 11 | $154 |
| Teva Pharmaceuticals USA, Inc. TEVA | 12 | $135 |
| Neurocrine BioSciences, Inc. NBIX | 7 | $129 |
| InSightec,Inc | 2 | $108 |
| Merz Pharmaceuticals, LLC | 6 | $104 |
| MDD US Operations, LLC | 5 | $92.11 |
| ACADIA Pharmaceuticals Inc ACAD | 3 | $51.5 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.